/ CompletedNot Applicable A single-center, randomized, double-blind, placebo-controlled, parallel-group studie investigating the safety, tolerability and pharmacokinetics of single- and multiple-ascending subcutaneous doses of TA-46 in healthy volunteers - TA-46 SAD and MAD dose study to investigate safety and PK
100 Clinical Results associated with Therachon SAS
0 Patents (Medical) associated with Therachon SAS
100 Deals associated with Therachon SAS
100 Translational Medicine associated with Therachon SAS